行情

MRNA

MRNA

MODERNA, INC.
NASDAQ

实时行情|Nasdaq Last Sale

17.75
-0.32
-1.77%
交易中 14:13 09/23 EDT
开盘
18.24
昨收
18.07
最高
18.47
最低
17.56
成交量
167.85万
成交额
--
52周最高
29.79
52周最低
11.54
市值
57.58亿
市盈率(TTM)
-11.7878
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

MRNA 新闻

  • 3 Biotech Stocks Surging on Positive Results
  • TipRanks.7小时前
  • What Kind Of Investor Owns Most Of Moderna, Inc. (NASDAQ:MRNA)?
  • Simply Wall St..3天前
  • 投资者关系互动平台
  • 雪球综合.6天前
  • Moderna Wants the Body to Make Its Own Drugs. Analyst Sees Significant Progress.
  • Barrons.com.09/13 15:02

更多

所属板块

制药
-0.31%
制药与医学研究
-0.38%

热门股票

名称
价格
涨跌幅

MRNA 简况

Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.
展开

Webull提供Moderna Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。